Verici Dx plc (AIM:VRCI)
London · Delayed Price · Currency is GBP · Price in GBX 0.4005
-0.0245 (-5.76%)
May 28, 2026, 3:34 PM GMT
Verici Dx Market Cap
Verici Dx has a market cap or net worth of 6.43 million as of May 28, 2026. Its market cap has increased by 92.86% in one year.
Market Cap
6.43M
Enterprise Value
6.30M
Revenue
1.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.40
Market Cap Chart
Since November 3, 2020, Verici Dx's market cap has decreased from 51.74M to 6.43M, a decrease of -87.57%. That is a compound annual growth rate of -31.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 6.43M | -41.38% |
| Dec 31, 2025 | 10.97M | 16.74% |
| Dec 31, 2024 | 9.40M | -43.40% |
| Dec 29, 2023 | 16.61M | -22.00% |
| Dec 30, 2022 | 21.29M | -71.66% |
| Dec 31, 2021 | 75.13M | -9.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 216.52B |
| GSK plc | 76.85B |
| Haleon | 30.29B |
| Smith & Nephew | 9.72B |
| GENinCode | 8.10M |
| Renalytix | 7.87M |
| Oxford BioDynamics | 7.64M |
| OptiBiotix Health | 5.94M |